V. G. Kiktev

V. G. Kiktev

Auto-generated profile, based on publicly available information

V. G. Kiktev

Chazov National Medical Research Centre of Cardiology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2021 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
APA. V. Pevzner
A. V. Pevzner
EKE. A. Kuchinskaya
E. A. Kuchinskaya
VKV. G. Kiktev
V. G. Kiktev
GKG. I. Kheimets
G. I. Kheimets
Vasovagal syncope (VVS) can occur in every third of human population. Clinical symptoms of VVS areas a result of arterial hypotension with critical global cerebral hypoperfusion due to vasodilatation and bradicardia. Bradicardia is manifested as sinus node dysfunction and atrioventricular conduction disturbances due to activation of nervus vagus. Asystole can take place in some cases. Lack of efficacy of permanent pacemaker founds in patients to prevent of VVS. The results of double blind placebo controlled studies, European and American expert's opinions, probable causes of lack of efficacy of pacemakers in such category of patients and way of solution of this problem are discussed in the review. Syncope recurrences in spite of pacemaker implantation, risk of surgery complications and good life prognosis are arguments for therapeutic approach, now suitable for the most of patients with VVS. Case report (VVS with asystole but without of pacemaker implantation) with successful follow-up is analyzed in the article.

24 April 2023 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
IKI.I. Ksanaev
I.I. Ksanaev
APA.V. Pevzner
A.V. Pevzner
ALA.YU. Litvin
A.YU. Litvin
EEE.M. Elfimova
E.M. Elfimova
OMO.O. Mikhailova
O.O. Mikhailova
GKG.I. Kheimets
G.I. Kheimets
У больных с сердечно-сосудистыми заболеваниями дыхательные нарушения во время сна встречаются значительно чаще, чем в общей популяции. Имеется противоречивая информация о роли этих нарушений в риске возникновения желудочковой тахикардии (ЖТ) и фибрилляции желудочков (ФЖ). ЦЕЛЬ ИССЛЕДОВАНИЯ Определение частоты встречаемости дыхательных нарушений во время сна, их выраженности и структуры у больных с имплантированными кардиовертер-дефибрилляторами (ИКД), а также оценка возможной роли этих нарушений в развитии рецидивов ЖТ и ФЖ. МАТЕРИАЛ И МЕТОДЫ В исследование включено 67 больных в возрасте от 34 до 83 лет, медиана 65 лет, из них 54 (81%) мужчин с индексом массы тела более 25 кг/м2. Всем больным в целях первичной [35 (52%) пациентов] или вторичной [32 (48%) пациентов] профилактики внезапной сердечной смерти были установлены трехкамерные (22—33%), двухкамерные (42—62,5%) или однокамерные (3—4,5%) ИКД. По данным обследования, доминирующей патологией, приведшей к устойчивым желудочковым аритмиям, была ишемическая болезнь сердца и постинфарктный кардиосклероз — 44 (65,5%) больных, 50 (75%) больных имели признаки хронической сердечной недостаточности II—III функционального класса по Нью-Йоркской классификации. Всем больным было выполнено кардиореспираторное мониторирование (КРМ). В ходе длительного наблюдения за больными анализировали функцию ИКД, особое внимание обращали на параметры, характеризующие наличие рецидивов устойчивой ЖТ и ФЖ, а также способы их купирования. РЕЗУЛЬТАТЫ По данным КРМ, дыхательные нарушения во время сна диагностированы у 64 (95,5%) больных, в 23 (34,5%) случаях определена легкая, в 22 (33%) — среднетяжелая, в 19 (28%) — тяжелая степень этих нарушений. Во всех случаях выявленные дыхательные нарушения сна носили обструктивный характер, но у 19 (28,5%) больных они сочетались со значимыми (индекс апноэ-гипопноэ >5 событий/час) эпизодами центрального апноэ. Анализ данных ИКД при длительном наблюдении (медиана 40 мес) не выявил статистически значимых различий между больными со среднетяжелыми и тяжелыми расстройствами дыхания (n=41) и пациентами с их отсутствием или легкой степенью выраженности (n=26) в рецидивировании устойчивых желудочковых аритмий, суточном (день-ночь) их распределении, необходимости нанесения электрических разрядов для купирования ЖТ и ФЖ, а также в склонности к непрерывно-рецидивирующему их течению (электрический шторм). ВЫВОДЫ Среднетяжелые и тяжелые дыхательные нарушения во время сна выявляются у 61% больных с ИКД. Во всех случаях они носят обструктивный характер, но у 28,5% пациентов сочетаются со значимыми эпизодами центрального апноэ. Наличие среднетяжелых и тяжелых дыхательных нарушений сна у больных с ИКД не сопровождается увеличением риска рецидивов ЖТ и ФЖ.

3 July 2020 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
MUM. D. Utsumueva
M. D. Utsumueva
NSN. B. Shlevkov
N. B. Shlevkov
VKV. G. Kiktev
V. G. Kiktev
ERElena M. Rimskaya
Elena M. Rimskaya
SKS. Yu. Kashtanova
S. Yu. Kashtanova
SGS. P. Golitsyn
S. P. Golitsyn
Patients with dilated cardiomyopathy (DCM) often have intraventricular conduction disorders, which contribute to aggravation of heart failure, are progressive in most cases and can specify the prognosis of the disease. Paroxysmal supraventricular arrhythmias in such patients proceed with severe clinical manifestations, often accompanied by hemodynamic instability and syncope. A case report of patient (59 years old) with DCM, reduced left ventricular ejection fraction (35-37%), left bundle branch block, and paroxysmal orthodromic reciprocating tachycardia is presented. When an electrode was inserted on the right ventricular (RV) apex during the radiofrequency ablation, a third-degree atrioventricular (AV) block was recorded. This was maintained during the operation and was recurrent when trying to remove the electrode from the RV apex, and therefore there was a need for temporary and then permanent cardiac pacing therapy. Given DCM, reduced left ventricular ejection fraction, left bundle branch block, and the expected high percentage of RV pacing, a decision was made to implant a cardiac resynchronization therapy defibrillator. The literature review considers risk factors for formation of third-degree AV block during cardiac catheterization, methods of its prevention, as well as discusses the prognostic significance of catheter-induced conduction disorders, and indications for temporary and permanent cardiac pacing therapy.

13 March 2024 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
GTG.S. Tarasovskiy
G.S. Tarasovskiy
NSN.B. Shlevkov
N.B. Shlevkov
TET.V. Ezhova
T.V. Ezhova
TMT.A. Malkina
T.A. Malkina
KBK.V. Belik
K.V. Belik
SGS.P. Golitsyn
S.P. Golitsyn
Currently, a remote monitoring system is recommended for more effective monitoring of patients with implanted cardioverter defibrillators (ICDs). OBJECTIVE To analyze the feasibility of remote monitoring system for prediction of ventricular tachyarrhythmias in patients with ICD. MATERIAL AND METHODS The study included 104 patients (69 men/35 women), aged 60±15 years with ischemic (n=73) or non-ischemic cardiomyopathy and sustained VT (n=86) throughout the follow-up period (median 41 months). We retrospectively assessed the following parameters 1, 2 and 4 weeks, as well as 3 months before each episode of VT using remote monitoring system: daily activity, mean heart rate, heart rate variability (SDNN), percentage of atrial and ventricular pacing, non-sustained and/or sustained (>30 sec) episodes of VT, atrial fibrillation and episodes of anti-tachycardia pacing/electroconvulsive therapy. Univariate, ROC and multivariate analyses identified the following parameters of remote monitoring system associated with VT: VT ≤180 beats/min and so-called «fast VT/VF» (VT >180 beats/min or ventricular fibrillation). The control group included patients without arrhythmic events (n=80). RESULTS VT type had no significant relationship with age and gender of patients, etiology of cardiomyopathy, antiarrhythmic therapy and follow-up, as well as parameters of remote monitoring system. Predictors of any VT: 1) ICD therapy within the last 3 months; 2) non-sustained VT over the past 3 months; 3) non-sustained VT over the past 7 days; 4) nighttime heart rate increase by more than 5 beats per minute during the last 7 days; 5) SDNN variations over the last 7 days. Identification of 3 out of 5 signs made it possible to predict VT with accuracy of 82% (sensitivity 90%, specificity 76%). CONCLUSION We developed an algorithm for prediction of VT using remote monitoring system. These results can be used for timely prescription or correction of antiarrhythmic and other therapy.

30 May 2024 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
ERElena M. Rimskaya
Elena M. Rimskaya
MBMaria Beliaeva
Maria Beliaeva
NMN. A. Mironova
N. A. Mironova
SDS. V. Dobrovolskaya
S. V. Dobrovolskaya
GTG. S. Tarasovskiy
G. S. Tarasovskiy
SGS. P. Golitsyn
S. P. Golitsyn
Aim. To evaluate the survival and dynamics of clinical and instrumental data in patients with chronic heart failure (CHF), atrial fibrillation (AF) and cardiac contractility modulation (CCM).Methods. There were included 54 patients (40 men, median age 59.7 [56.6; 63.9] years) with signs of CHF II (n=27, 50%) functional class and III (n=27, 50%) NYHA functional class, significantly decreased left ventricular ejection fraction (LVEF=30 [24,7; 35,5]%), LV dilatation and paroxysmal (n=27, 50%) or permanent (n=27, 50%) AF. In all patients, devices for CCM were implanted. The dynamics of clinical and instrumental parameters were assessed in 2, 6, 12 and 24 months after implantation. The actual survival patients with CCM was compared with the predicted survival calculated using the Seattle model of heart failure and MAGGIC risk score.Results. In 14 (28%) of patients CCM resulted in significantly increased clinical, echocardiographic parameters (increase in LVEF by 15 [11; 20]%, decrease in end-systolic volume by 68,5[37.5;104.5] ml and end-diastolic volume by 44 [30,100] мл), increase in walking distance during 6-minute walking test and decrease of NT-proBNP. The only factor significant for maximal response was non-ischemic etiology of CHF (χ2=4.54, p=0.034). During 2 years 21 (42%) patients died. The all-cause mortality in patients with CCM to the first year of observation was 16%, two-year all-cause mortality - 40%. These figures turned out to be significantly higher than predicted according to the Seattle model (χ2=10.93, p=0.001). The predicted and actual risk of death at 12-month follow-up turned out to be comparable when assessing survival parameters according to the MAGGIC scale. (χ2=2.24, p=0.134).Conclusion. CCM therapy in some patients with CHF of non-ischemic etiology can lead to an improvement of all clinical and instrumental characteristics. At the same time, there is no effect of CCM on the prognosis of patients with CHF. This fact may suggest the need of additional studies with increased number of cases.

25 December 2025 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
PDF file
IKI.I. Ksanaev
I.I. Ksanaev
APA.V. Pevzner
A.V. Pevzner
ALA.YU. Litvin
A.YU. Litvin
EEE.M. Elfimova
E.M. Elfimova
OMO.O. Mikhailova
O.O. Mikhailova
NSN.B. Shlevkov
N.B. Shlevkov
Objective. To assess diagnostic efficacy of screening methods for sleep-disordered breathing — questionnaires (assessing the risk of obstructive sleep apnea and daytime sleepiness), overnight pulse oximetry and apnea detection algorithm embedded in implantable cardioverter-defibrillators (ICDs) in patients with ICDs. Material and methods. The study included 67 patients aged 34-83 years (median 65). There were 54 (81%) men, median body mass index was 29.4 kg/m2. All patients underwent CRM to detect sleep-disordered breathing. Screening performance of various diagnostic methods for sleep apnea detection was assessed in 39 patients using STOP-Bang questionnaire and Epworth Sleepiness Scale (ESS), in 20 patients — using computer-based pulse oximetry (PO), in 7 patients — via interpretation of respiratory disturbance index obtained from ICDs of specific models. Results of these screening methods were compared with CRM data. Results. According to CRM data, sleep-disordered breathing was detected in 64 (95.5%) patients (mild in 23 (34.5%), moderate in 22 (33%), and severe in 19 (28%) cases). In all cases, sleep-disordered breathing was obstructive, but 19 (28%) patients had combination with significant (more than 5 events/hour) episodes of central apnea. Compared to CRM data, sensitivity of STOP-BANG questionnaire in diagnosis of sleep-disordered breathing was 92% (specificity 33%). Sensitivity of ESS was 44%. Sensitivity of computer-based pulse oximetry for detecting sleep-disordered breathing was 100%. In 3 cases, computer-based pulse oximetry substantially underestimated severity of sleep-disordered breathing compared to CRM. Overestimation was noted in other 3 cases. In all 7 patients in whom respiratory disturbance indices were obtained from ICDs, mean overnight values indicated sleep-disordered breathing that was confirmed by CRM. In 3 patients with mild SDB confirmed by CRM, apnea detection algorithm in ICD markedly overestimated respiratory event index. Conclusion. In patients with ICDs, SDB is diagnosed in 95.5% of cases with moderate-to-severe forms identified in 61% patients. Compared to CRM data, STOP-BANG and ESS scales in patients with ICDs are not reliable in identifying SDB and cannot be recommended as the main screening methods. High sensitivity of computer-based pulse oximetry in detecting SDB, when compared with CRM data, supports recommendation of this method for screening in patients with ICDs.